ENDOCRINE THERAPY FOR ADVANCED-CARCINOMA OF THE BREAST - EFFECT OF TUMOR HETEROGENEITY AND SITE OF BIOPSY ON THE PREDICTIVE VALUE OF PROGESTERONE-RECEPTOR ESTIMATIONS
- 1 January 1987
- journal article
- research article
- Vol. 47 (1), 296-299
Abstract
This study was carried out to assess the influence of site of biopsy and tumor heterogeneity upon the value of progesterone receptor (PR) measurements for prediction of response of patients with advanced carcinoma of the breast to tamoxifen or ovarian ablation. One hundred eighty-one assessable patients were studied. Sixty-nine % of responders and 31% of nonresponders were PR positive. The times to progression and survival were not significantly different for responders whether they were receptor positive or receptor negative. PR was measured on operable primary tumors (97), inoperable primary tumors (59), and secondary deposits (69). The proportion of responders who had PR-positive biopsies from these sites was 59%, 88%, and 61%, respectively, and the proportion of PR-positive nonresponders was 30%, 27%, and 42%, respectively. Ten to 12 separate PR measurements were made on seven tumors, and in four of them, there were PR-positive and PR-negative areas which could account for false positive and false negative results. We conclude that the optimum prediction of response was seen when the biopsy was performed on inoperable primary tumors. Errors in prediction of response at this site were, in part, explained by within-tumor heterogeneity of PR; the greater errors in prediction when measurements were made on operable primary tumors or on secondary deposits are presumed to be related to the additional effects of change in receptor status with time and between-tumor-site heterogeneity, respectively.This publication has 13 references indexed in Scilit:
- Receptor heterogeneity of human breast cancer as measured by multiple intratumoral assays of estrogen and progesterone receptorEuropean Journal of Cancer and Clinical Oncology, 1984
- MULTIPLE PROGESTERONE-RECEPTOR ASSAYS IN HUMAN-BREAST CANCER1984
- Progesterone receptor measurement by isoelectric focusing: a potential microassayClinica Chimica Acta; International Journal of Clinical Chemistry, 1983
- Variation of receptor status in cancer of the breastBritish Journal of Cancer, 1983
- Treatment of advanced breast cancer with megestrol acetate after therapy with tamoxifenCancer, 1982
- Distribution of Estrogen and Progesterone Receptors on Primary Tumor and Lymph Nodes in Individual Patients with Breast CancerOncology, 1982
- ESTRADIOL AND PROGESTERONE RECEPTORS IN MULTIPLE TUMOR SPECIMENS FROM PATIENTS WITH BREAST-CANCER1980
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Assessment of response to therapy in advanced breast cancerEuropean Journal of Cancer (1965), 1977
- Predicting Response to Endocrine Therapy in Human Breast Cancer: A HypothesisScience, 1975